S100A8 and S100A9 are antimicrobial peptides that form a heterodimer called calprotectin which interacts with Toll-like receptor 4 (TLR-4) and exacerbates psoriasis by activating complement factor C3 and recruiting neutrophils [9,26]. This evidence concerns the gene S100A8 and psoriasis.